# US 8,278,275 B2 · Method to enhance hemodynamic stability using oxygen carrying compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,275 B2
- Document ID: US8278275B2
- Status: Granted
- Kind: B2
- Application number: 12/623,760
- Filed: 2009-11-23
- Published: 2010-04-08
- Granted: 2012-10-02
- Earliest claimed: 2004-08-31
- Assignees: Sangart, Inc.
- Inventors: Robert M. Winslow; Kim D. Vandegriff
- Web page: https://patentgrep.com/patent/US8278275B2

## CPC

- A61K 38/42: Haemoglobins; Myoglobins
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 7/08: Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P27/04)
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 41/00: Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to methods for enhancing the hemodynamic stability of an individual undergoing surgery by administering a composition comprising a hemoglobin-based oxygen carrier. In one embodiment, the present invention relates to the use of polyalkylene oxide modified hemoglobins with reduced cooperativity and a high oxygen affinity to enhance oxygen offloading as a preventative measure to avoid hemodynamic stability-related complications during surgery.

## Claims

### Claim 1

A method for reducing hypotensive events that may be experienced by a normovolemic subject during surgery, said method comprising the steps of:
a) providing a maleimide polyethylene glycol conjugated hemoglobin (MalPEG-Hb);
b) monitoring blood pressure of the normovolemic subject before, during and after surgery; and
c) administering the MalPEG-Hb to the normovolemic subject if the normovolemic subject exhibits hypotension;
wherein administration of the MalPEG-Hb to the normovolemic subject reduces hypotensive events.

### Claim 2 (depends on 1)

The method according to claim 1, wherein step c) is performed prior to surgery.

### Claim 3 (depends on 1)

The method according to claim 1, wherein step c) is performed during surgery.

### Claim 4 (depends on 1)

The method according to claim 1, wherein step C) is performed after surgery.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the polyethylene glycol (PEG) of the MalPEG-Hb is PEG 5000.
